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1. Introduction 
Physicians have historically shared an intuitive concept of Quality, concerning the care we 
provide to our patients. Our academic education and practice have been focused on Quality 
as a technical concept, assessable only by technicians and with no strong correlation with 
outcomes. The concept of Medicine as an Art is related to the values of vocation, dedication 
and good practice, recognizing that results can after all be negative 
In the XXI Century, we all now accept the scientific nature of Medicine and, therefore, its 
dependence on the objective assessment of outcomes. In contrast, the patient’s perception of 
Quality strongly depends on the culture and the environment. The current definition of 
disease given by the World Health Organization (WHO) focuses on self-perceived health 
and wellbeing. In this context, quality-based medicine should also be oriented towards the 
health and welfare as perceived by the patient. 
Quality is one of the strategic elements on which the transformation and improvement of 
modern health systems is based. The effort made in recent years towards quality assurance 
in this field –including in the particular case of nephrology-, entails recognition of the need 
for objective and standardized measurement tools for health activities: Quality is not just 
good intentions. 
2. Definitions of quality 
There are many definitions of Quality, which in itself suggests that none of them are 
comprehensive. Definitions focused on Quality in Health, mainly date from the 1980’s, 
when Palmer, Donabedian (Donabedian, 1980), the American Medical Association and 
many other authors tried to develop an adequate definition. As early as 1990, the Institute of 
Medicine adapted the definition given by the ISO (International Organization for 
Standardization), which does not specifically refer to Health: "Quality is the degree to which 
the characteristics of a product or service meet the objectives for which it was created”, 
defining Quality in Medicine as “the degree to which health services for individuals and 
populations increase the likelihood of desired health outcomes and are consistent with 
current professional knowledge”(Lohr, 1990). This is the current philosophy of Medical 
Quality, which assesses the results, both objective and perceived by the patient (Committee 
on Quality of Health Care in America, 2001), assuming a degree of uncertainty with respect 
to processes and the final outcomes.   
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Quality in patient care depends on a large number of factors, but doctors tend to consider 
only a few, such as efficacy and effectiveness, more recently including accessibility, 
efficiency, privacy, and safety, among others as respect for the environment. Some factors 
are of great interest to Society as a whole - like those just listed - while others may be 
interesting primarily for patients, such as timeliness, convenience, patient participation, etc. 
The restrictive view of Quality used by doctors explains the differences we find between the 
technical quality and the quality perceived by the patients (JCAHO: Agenda for change, 
1989).  
2.1 Quality models 
Although all models of quality are based on common ideas, such as reducing the variability 
in medical practice through standardization -using standards and indicators-, two types of 
quality models can be distinguished with respect to their underlying purpose. On the one 
hand, some models pursue standardization. This involves assessment by a qualified and 
independent entity that will accredit or certify us for providing high quality medical care. 
On the other hand, there are models that aim for continuous quality improvement based on 
self-monitoring. These produce continuous feedback that should help eliminate errors and 
lead to improvements in outcomes.   
These two types of models are by no means exclusive. In Europe, public hospitals 
commonly use the European Foundation for Quality Management (EFQM) model, which 
not health specific: 
(http://www.efqm.org/en/Home/aboutEFQM/tabid/108/Default.aspx); while, providers 
in the United Stated and private centers in Europe have chosen accreditations based on the 
standards of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO, 
1989; JCAHO update, 1990; JCAHO, 2011).    Meanwhile, in Latin America the EFQM model 
is adopted more widely through the Latin American Foundation for Quality Management 
(FUNDIBEQ; www.fundibeq.org ). 
The Joint Commission uses a wide range of indicators and standards from the National 
Institute of Standards and Technology (NIST) -355 in the international version, of which 171 
are mandatory for accreditation-, divided into medical and organizational indicators. They 
can be accessed from www.jointcommission.org or www.quality.nist/gov/.  
The EFQM model allows centers to choose their indicators and standards -as long are they 
are logical and supported by scientific evidence- and pays greater attention to the evolution 
of the indicator towards "Excellence", than to the achievement of a standard at a given time. 
In other words, centers are not valued for their good work, but for their year-on-year 
improvement.  
Another important difference from an operational point of view is that the Joint 
Commission certifies Centers -although it may also test Units- and assesses both clinical and 
other organizational, structural, plant safety and accessibility indicators. On the other hand, 
the European model can readily be applied to processes. For example, it is possible to apply 
the EFQM to a chronic hemodialysis process, peritoneal dialysis, nephrology hospitalization 
ward or kidney transplantation unit. Therefore, we can first apply it to one of the processes 
in our Service or Hospital, and within a few years extend it to other processes. It should be 
noted that processes are only one part of the EFQM (Figure 1), a useful aspect of the model 
is that we  can start by applying it into individual processes, based on the priorities of clients 
and employees. Later on, the analysis can evolve to address common issues for the Hospital, 
such as leadership and strategy. 
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Finally, the European model can theoretically be implemented with no additional economic 
cost (the only requirement being training in use of the model), while those who pursue 
international accreditation need to pay the evaluators. There is a cost calculator on the Joint 
Commission’s website, and it should be noted that the center’s accreditations have to be 
renewed every three years.  
In this context, we note that dialysis is a high cost therapy that can rarely be paid for by the 
patient. Funders have the authority -and obligation- to monitor the quality of the Healthcare 
for which they pay. Therefore, they increasingly demand the accreditation of Dialysis Units. 
Evaluators are usually independent from the payer, and they act as intermediaries between 
the payer and the health provider. Nevertheless, even in the accreditation systems, 
evaluation is considered as an element to guide these units in making improvements. 
In this chapter, we will consider a quality system focused on a continuous improvement 
(rather than quality accreditation) that every dialysis unit could adopt if so desired. 
 
 
Fig. 1. European Foundation for Quality Management. Model of Excellence. 
2.1.1 Quality systems in dialysis 
Initially, quality systems have been used in acute care processes (mainly surgical), as well as 
general services such as laboratories, radiology units, etc. Quality indicators in these cases 
are derived from different patients who undergo a procedure at different points in time. 
However in dialysis, patients continue treatment over periods of months and years, and this 
implies several conceptual changes. It is clear that dialysis is not a curative procedure, but 
rather a life support technique. Its purpose is then to prolong life and improve its quality. 
Accordingly, indicators that seek to measure the quality of a certain dialysis therapy should 
be correlated with those two endpoints: survival and quality of life. 
2.1.2 Quality systems in peritoneal dialysis  
Quality systems in hemodialysis have been implemented for two decades, fundamentally, 
due to accreditation requirements. However, peritoneal dialysis (PD) is performed at the 
patient's home under clinical guidance depending on the general hospital, itself already 
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under global assessment and accreditations. That dependence explains why quality systems 
in PD have not been prioritized. The EFQM model can be applied to isolated processes, so it 
can be used in Peritoneal Dialysis Units. 
The full EFQM model (Total Quality Management) includes the assessment of multiple 
criteria, grouped into facilitators (5 types) and results (4 types).  
In this chapter, we will only describe the PD process (as a part of the Dialysis Process) and 
the most appropriate indicators and standards for its evaluation.. 
3. The peritoneal dialysis process 
The process includes information concerning the alternative techniques of dialysis offered to 
patients from which they can choose, and withdrawal from the PD program due to death, 
transplantation, changing to hemodialysis or recovery of renal function. As hemodialysis 
and PD have a similar start and end, and the same therapeutic purpose, we have grouped 
them under a single process of chronic dialysis, with its two main variants (Figure 2). 
Logically, the dialysis process is part of a series of support processes including those of the 
laboratory, pharmacy, maintenance, etc. The description of each activity in the process 
(Table 1) should not be exhaustive but rather refer to specific protocols that need to be 
written, accessible to all staff and regularly updated. However, it is important that there is a 
designated person in charge of each activity in the process and a record of the activity that 
could be consulted if necessary (Lopez-Revuelta et al., 2002; Arenas, 2006).  
The process of peritoneal dialysis is a part of a more complex dialysis process that includes 
all the renal replacement therapies (Figure 2). Patients’ opinions and medical 
contraindications determine the decision between the three main alternatives for dialysis, 
whether as a definitive therapy or as life support waiting for kidney transplantation. In this 
chapter we consider only the indicators of quality for the home peritoneal dialysis option.     
3.1 Characteristics of clinical quality indicators  
A clinical indicator is a quantitative measure that can help us monitor and evaluate quality 
in care activities and support services. It is not a direct marker of quality, but rather can 
serve to alert to areas which require specific action within a healthcare organization 
Indicators express information as numbers of events or ratios. In the latter case, the 
denominator is the number of patients among whom the event could potentially occur. 
Although the event selected is undesirable, in general it should occur commonly enough to 
be used as an index. There is, however, a special kind of indicator that cannot be expressed 
as an index or a ratio: the Sentinel Event Indicator, that measures events which are 
undesirable, preventable, rare and have serious outcomes. When detected, such indicators 
warrant a thorough investigation and urgent action (even if there is just one case).  
Indicators can measure either processes or results. The best process indicators are those 
closely linked to patient outcomes, and for which there is scientific evidence that indicates 
that the care provided will lead to a specific result. In the event that the result of a process 
cannot be measured, or there is an excessive delay for corrective action, process indicators 
are the only type that can be used. 
Further, indicators can measure desirable or undesirable results. In the former case, the 
objective is that the vast majority of patients meet the criteria; while in the latter case, the 
aim is just the opposite. Ideally, the quality systems used by a given Unit should select only 
those indicators that represent desirable objectives, in order to avoid confusion. For instance,  
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Fig. 2. Dialysis Process. 
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ACTIVITY DESCRIPTION RESPONSIBLE REGISTRY 
Patient information 
about RRT techniques 
DIALYSIS GENERAL PROTOCOL 
Nephrologist 
PD nurse 
Clinical Record 
Nursing record 
Consent Form 
Indication for starting 
PD 
DIALYSIS GENERAL PROTOCOL 
Nephrologist 
PD physician 
Clinical Record 
Appointment for PD 
catheter insertion 
Written appointment, with date, time 
and premedication 
PD nurse Nursing record 
Deliver to patient 
Information about 
appointment for catheter 
insertion 
PERITONEAL DIALYSIS PROTOCOL PD nurse Nursing record 
Catheter insertion PERITONEAL DIALYSIS PROTOCOL 
PD nephrologist 
or surgeon 
Lab Reports 
Clinical Record 
Incorporate in the RRT 
Registry and  waiting 
list for renal transplant 
On line data communication to RRT 
Registry Database, including 
Identification, Clinical and Serological 
Data, and required data for Kidney 
Waiting List 
Nephrologist 
RRT Registry. 
Waiting List for 
kidney 
transplant 
Convey to 
Administration and PD 
material provider about 
the patient 
To be done by email about patient 
information and chosen PD technique 
(CAPD or APD) 
Nephrologist 
E-mail and 
letter of 
approval 
Check PD catheter 
permeability 
PERITONEAL DIALYSIS PROTOCOL PD nurse Nursing record 
Patient PD training PERITONEAL DIALYSIS PROTOCOL PD nurse Nursing record 
Call the PD provider 
To finalize the supply of PD equipment 
at patient’s home from specific date 
PD nurse Nursing record 
Home visit or phone call 
to patient’s home 
After starting PD at home, some contacts 
asking for possible problems or doubts. 
PD nurse Nursing record 
Regular controls at 
hospital, or by phone, 
mail, web-cam, etc. 
PERITONEAL DIALYSIS PROTOCOL 
PD nephrologist 
PD nurse 
PD Graphics 
Nursing record 
Clinical Record 
To consider change in 
dialysis technique 
In case of patient’s decision or 
unsolvable problems. 
PD PROTOCOL 
PD nephrologist 
PD Graphics 
Nursing record 
Clinical Record 
Regular controls about 
studies and treatments 
of associated illnesses 
PERITONEAL DIALYSIS PROTOCOL PD nephrologist 
PD Graphics 
Clinical Record 
Regular control’s studies 
about Waiting List for 
kidney transplant 
PRE-TRASPLANT STUDIES 
PROTOCOL 
Nephrologist 
PD Graphics 
Clinical Record 
Reconsider situation in 
Waiting List for kidney 
transplant 
PRE-TRASPLANT STUDIES 
PROTOCOL 
Nephrologist 
PD Graphics 
Clinical Record 
RRT Registry 
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ACTIVITY DESCRIPTION RESPONSIBLE REGISTRY 
Discharge from PD due 
to partial improvement 
of renal function, change 
to hemodialysis, 
transplant or patient’s 
death. 
PERITONEAL DIALYSIS PROTOCOL Nephrologist 
Lab Reports 
Clinical Record 
Table 1. Peritoneal Dialysis: Activities in the Process. 
“peritonitis rate with a negative culture” is an indicator of low quality, a high rate 
suggesting poor quality in sample collection, transport or laboratory processing of 
peritoneal effluent. As this may not be intuitive, it is preferable to use the “peritonitis rate 
with a positive culture”, aiming for this indicator to exceed 80% of cases.  
In addition, indicators must be valid. This means they should identify situations in which 
quality in the healthcare provided can be improved (reflected in final outcomes). Validity is 
often only apparent and the indicator has to be "validated" afterwards. Lastly, indicators 
must be sensitive, able to identify real problems with care, avoiding “false positives”, and 
they must also be specific, so that they detect only these real problems.  
The selection of a set of indicators is a complicated task. It is preferable to select only a few, 
avoiding an increase in workload related to maintaining the database that would have no 
direct translation into improvements. From the selected recommendations, the quality 
indicators were drawn up according to a format which includes: their definition, criterion, 
equation, units, frequency of the assessment, standard, bibliographical references and 
comments. The methodologies proposed by the Joint Commission and the Standing 
Committee of the Hospitals of the European Union were followed by systems for 
monitoring healthcare processes. These have been complemented by the specific HD 
methodology that is followed by the American ESRD Special Project and implemented by 
the Centres for Medicare and Medicaid Services (CMS) -such as in the ESRD Clinical 
Performance Measures (CPM) Project-. Initially, quality criteria were selected from each 
recommendation for measurement of performance. The indicator is a quantitative 
measurement to evaluate a criterion. A “standard” was set for each indicator (namely, the 
required degree of performance to ensure an acceptable level of quality) based on scientific 
evidence or, in its absence, by consensus. On many occasions, sufficient scientific evidence 
was not available, but experience derived from the follow-up of indicators will help us 
adjust and redefine them in the future. Those interested in understanding the subject more 
deeply, should consult the 1989 and 1990 JCAHO references.  
3.2 Quality indicators in peritoneal dialysis  
Traditionally (Donabedian 1980; JCAHO, 1989), we distinguish between structure, process 
and outcome indicators. Variations in the quality of the structure or the process tend to 
influence the outcomes. Structure Indicators are highly valued for accreditation, as adverse 
results caused by structural defects imply a greater responsibility if patients file lawsuits. 
However, we assume process indicators are a more accurate reflection of quality than those 
directly related to outcomes, as they detect systematic errors and their correction  more 
commonly produces improved outcomes (Williams et al, 2006; Ballard, 2003).  
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Indicators must monitor quality. Therefore, they should be correlated to survival or quality 
of life of the patients, and be based on scientific evidence. In our case, we based them on the 
Clinical Practice Guidelines in PD, recently published by the Spanish Society of Nephrology 
(Arrieta, 2006). Following the publication of these guidelines, a panel of peritoneal dialysis, 
with the support of the Quality Management in Nephrology Group (a working group of 
Spanish Society of Nephrology), designed a definition for quality indicators and standards 
that can be used by all the nephrology community -especially those dedicated to PD-. The 
new definitions would also serve as a framework or terms of reference for future areas of 
improvement, filling the gap between the development of guidelines and subsequent 
monitoring.  
Often, we found that there was not sufficient scientific evidence to define a standard. In 
these cases, we proposed a provisional framework that should be evaluated later. Earlier in 
this chapter, we have explained that continuous improvement objectives should be set by 
each unit, based on local outcomes. 
Whatever the result of applying an indicator in a given unit, what is important is that they 
guide improvement activities, and there will then be ongoing monitoring of whether such 
measures are effective. In fact, indicators are basically an internal tool that permits 
comparisons with our own previous performance and helps us assess our own 
improvement. In the future, the pooling of results from different institutions would 
determine the appropriate quality standards in peritoneal dialysis for the Spanish 
population. 
Having similar quality criteria in all centers is a medium-term objective, as we are all 
interested in comparing our results and assessing whether variations in clinical practice lead 
to different final outcomes (Jha et al., 2005).  
On the other hand, it has been shown that regular measurement of quality indicators –and 
the fact of having set up targets and standards- encourages monitoring and improves the 
outcomes of the process (Williams, 2005; Fink, 2002).  
The initial list of indicators, standards and objectives selected includes a large number of 
indicators that have been already established for hemodialysis. As the most prevalent renal 
replacement technique, many Quality Systems have already been developed in that field 
(Lopez-Revuelta et al., 2007). Nevertheless, we should always consider those indicators or 
standards that have not been specifically validated for PD patients as provisional, and focus 
on the survival and quality of life outcomes instead.  
There are usually too many indicators. Each unit should select those that seem most relevant 
to its daily routine. In addition, data management technologies become a priority. A wide 
range of computer software (Renalsoft®, Nefrolink®, Nefrosoft®, Versia® etc.) is used in 
peritoneal dialysis and hemodialysis units in Spain. In some cases, more advanced 
programs are being developed and adopted than enable quality indicators to be estimated 
automatically and rapidly.  
In the following sections, we will describe the initial selection of Quality Indicators used by 
the Spanish Society of Nephrology (currently, at the evaluation stage). They are Clinical 
Indicators, so they have to be supplemented with Structure Indicators, Satisfaction Surveys 
and Quality of Life Questionnaires for patients. From a business point of view, and in order 
to obtain Accreditations of our units, it is also a good idea to carry out Satisfaction Surveys 
of our staff and suppliers.  
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3.3 Classification of peritoneal dialysis indicators  
We use Global Indicators and Comorbidity Indicators to describe patients (Table 2). Most of 
these are not quality indicators but Registry data, local practice frameworks or terms of 
reference which enable us to identify certain patient and PD unit characteristics that may 
influence outcomes and modify other indicators. It is interesting to see how their evolution 
pans out over time. In some cases, they do indicate aspects of the quality of medical 
attention before starting PD, but our intention is to use them to adjust the evaluation of 
Outcome Indicators. The modified Charlson Index (Bedhu et al., 2000) extends the item 
“Documented History of Myocardial Infarction” to include another one namely “Ischemic 
Heart Disease (CHD)”, which includes all forms of coronary heart disease (angina, 
myocardial infarction, angiographic evidence of coronary artery disease history of 
angioplasty or bypass surgery). For this reason, we consider it more appropriate for the 
usual profile of PD patients.  Global and Comorbidity Indicators are collected annually, as 
they are not used to make improvements. The Charlson Index is measured at the start of PD 
and, as it can only increase, it is reassessed once or twice a year. 
Outcome Indicators (Table 3) (Arrieta et al., 2009; Bajo et al., 2010) include more up-to-date 
data, such as the rate of infections associated with the technique, the adequacy of the 
dialysis dose, test results and medications taken. These Indicators can alert us to deficiencies 
in the initial stages of treatment, and early correction can rapidly improve outcomes. 
Usually, they are compiled twice a year, but with a good IT system they can be calculated 
and consulted as often as is agreed to be appropriate in each unit, though clearly this 
involves additional work.  
Other indicators such as rates of hospitalization or withdrawals from DP should be explored 
more carefully, as they are influenced by local characteristics, the socio-cultural context and 
the availability of replacement therapy.   
 
GLOBAL INDICATORS 
PD Incidence 
Period Prevalence (prevalents at begin of period + incidents) 
Mean age of incidents 
Mean age of prevalents 
Sex rate of incidents y prevalents 
Mean time in PD treatment of prevalents 
Percent of diabetics among incidents 
        “    of incidents not dialyzed before 
        “  “ coming from HD 
        “  “ coming from TX 
        “     of incidents with a signed Informed Consent about all RRT 
techniques 
        “     of prevalents on CAPD (vs total in PD techniques) 
COMORBIDITY INDICATORS 
Median of Modified Charlson Index in incidents 
Median of Modified Charlson Index in prevalents 
Table 2. Quality Indicators at starting PD. 
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OUTCOME INDICATORS (1)    (ANNUAL INDICATORS) 
Hospitalization  
  admissions 
  average days by admission  
Exits from PD 
  totals 
  change to HD 
  deaths 
  transplants 
Transplants 
             percent of patients in Kidney Tx Waiting List (WL) (among prevalents in PD) 
  mean time in PD before inclusion in WL 
  annual rate of transplants in PD patients (among patients in WL) 
  mean time in PD before kidney Tx 
  mean time between Tx and PD catheter extraction    ¿< 1-3 months? 
OUTCOME INDICATORS (2)      (SEMESTER INDICATORS) 
Infections (limited to PD technique)  
  rate of peritonitis          ¿< 0.5 / pte / yr? 
  partial rates in APD and CAPD  
  percent of peritonitis with a positive culture (identified germ)  
          “    of peritonitis by Gram + 
                  by Gram – 
                  by fungus 
          “     of peritonitis “catheter dependent” 
  rate of infections of catheter exit site 
  rate of patients with nasal cultures (positive or not)                >80% 
Adequacy and membrane function 
 percent of patients with an urea KT/V measured in the semester                >80% 
         “    of patients with urea KT/V  > 1.7                  >80% 
         “    of patients not anurics with Renal Residual Function measured             >80% 
         “    of patients with a daily UF rate  > 1000ml/ day                 >80% 
         “    of patients using daily one or more hypertonic bags (3.86 / 4.25%)        <20% 
         “    of patients with a PET performed in the 3 months alter starting PD       >80% 
         “    of patients with a PET performed annually                 >80% 
         “    of patients resulting High Absorbers in PET. (D/P Cr 4h > 0.81)      
Analysis and medication 
 percent of patients within Hb objective  (11 to 13)                                  >80% 
         “    of patients with serum ferritin  > 100                  >80% 
         “    of patients with Index of Resistance to EPO  < 9                 >80% 
         “    of patients with I.R. to darboepoetin  < 0.045                 >80% 
         “    of patients with serum cholesterol LDL < 100                 >80% 
         “    of patients with serum albumin  > 3.5                  >80% 
         “    of patients with serum phosphate  < 5.5                                  >80% 
         “    of patients with serum corrected calcium > 8.4  and < 9.5                >80% 
         “    of patients with Ca x P <  55 (in mg/dL)                                  >80% 
         “    of patients with PTH < 300                   >80% 
Table 3. Quality Indicators of Outcomes.   
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Calculation of the rate of occurrence of a certain outcome may present problems in units 
with few patients. We recommend estimating the prevalence of “at-risk” patients per 
month, to determine the “real” total number of patients to be used in the denominator of the 
ratios (Jager et al., 2007). 
3.4 Standards and objectives of quality indicators  
Every indicator should have a clear definition, a target or objective (threshold or range), and 
a standard for assessing compliance. We have defined objectives when there is a reasonable 
amount of scientific evidence to support them. However, such evidence is often not 
sufficiently tested in PD (though it may have been tested in HD patients or in the general 
population, as is the case of LDL cholesterol levels). The original standard is commonly set 
at the percentage of patients who meet the target. For clarity, we prefer to express the degree 
of compliance than the rate of "non-compliance".  
It is important that targets are always to be established based on scientific evidence. For 
instance, the hemoglobin target is set at 11 mg/dL or above because the Guidelines for 
Good Clinical Practice (based on hemodialysis) agree on this level; nevertheless; PD patients 
may have Hb higher than 13 in the absence of EPO. Accordingly, we will not set a maximum 
target as we do in HD. The standard is a given rate of compliance with objectives -usually 
80% to 85%-, and is later adapted to the real results obtained and the real possibilities of 
achieving the Standard in our healthcare context. 
When we initially apply an indicator in our units, we may find that our compliance rates are 
very low. This could mean that the target was too high, the indicator was not appropriate or, 
even, that the sample of patients on which the assessment if based are really ill. The 
objective must be based on high-grade evidence. If it is well established, we must strive to 
achieve it over time and accept a low compliance rate, re-evaluating the rate once or twice a 
year.  
I insist that a good progress is more important than a good result. Evidence is often drawn 
from clinical trials involving highly selected patients, with a high rates of adherence to 
prescribed medication  (which is often free during the trial) and under close medical 
supervision. These results would be very difficult to achieve in routine practice. In any case, 
it is absolutely not permissible for the threshold for compliance with an objective to be 
lowered as a means of achieving a better rate of compliance, unless on reconsideration it is 
judged that the target is not supported by current evidence, or that the effort required to 
achieve the target is not justified by real improvements in the final outcome measures 
(namely, survival and quality of life). 
Finally, we must remember that just measuring outcomes tends to produce an 
improvement in clinical practice (Williams et al., 2005; Fink et al., 2002). It has also been 
proven that, in hemodialysis, the level of compliance with quality standards is directly 
related to mortality and morbidity, although most of the standards applied have not yet 
been validated (Rocco et al., 2006; Plantiga et al., 2007). From a theoretical standpoint, this 
introduces a bias towards the validation of an Indicator or a Standard, but it should also 
encourage doctors to use the quality control systems as tools for continuous improvement 
of our daily practice, rather than consider them as management tools with little relevance 
to medical practice. 
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4. Conclusion  
It has already been demonstrated that the regular measurement of quality indicators –as 
well as having standards and establishing objectives-, helps to improve the monitoring and 
results of the dialysis process, and contributes to improving outcomes in terms of patient 
morbidity and mortality. Access to management software becomes a priority. A Quality 
System should be focused on achieving Continuous Improvement of Quality expressed in 
terms of Survival and Quality of Life. Patients’ opinion about self-perceived health and 
wellbeing and about quality of health care must be considered. Accreditation of the Unit 
should not be a final objective.  
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